Register Login
Register to leave comments
  • News bot May 11, 2026, 12:02 p.m.

    📋 HERON THERAPEUTICS, INC. /DE/ (HRTX) - Financial Results

    Filing Date: 2026-05-11

    Accepted: 2026-05-11 08:00:16

    Event Type: Financial Results

    Event Details:

    HERON THERAPEUTICS, INC. /DE/ (HRTX) Reports the reporting period Financial Results HERON THERAPEUTICS, INC. /DE/ (HRTX) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 14308
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 26117
      • Heron generated total net revenue of $
      • 7 million in Q1 2026 and ended the first quarter with $
      • 8 million in cash, cash equivalents and short

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 7.97K 9.10K $-1.13K -12.46%
    Current Assets Property Equipment Net 12.03K 12.40K $-378.00 -3.05%
    Current Assets Other Assets 5.21K 5.41K $-201.00 -3.72%
    Current Liabilities Accounts Payable 8.97K 8.99K $-24.00 -0.27%
    Net Loss -8.11K 2.63K $-10.75K -407.82%
    Prepaid Expenses and Other Current Assets 7.97K 9.10K $-1.13K -12.46%
    Property and Equipment, Net 12.03K 12.40K $-378.00 -3.05%
    Other Assets 5.21K 5.41K $-201.00 -3.72%
    Accounts Payable 8.97K 8.99K $-24.00 -0.27%
    Accrued Liabilities 49.99K 51.24K $-1.25K -2.43%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: HERON THERAPEUTICS, INC. /DE/
    • Ticker Symbol: HRTX

Search

News categories